New combo may cut painful eye injections for vision loss
NCT ID NCT00527475
First seen Jan 07, 2026 · Last updated May 13, 2026 · Updated 22 times
Summary
This study tested whether adding a light-based therapy (photodynamic therapy) to a standard drug injection (ranibizumab) could reduce the number of injections needed for wet age-related macular degeneration. 60 participants aged 50 and older with active disease were enrolled. The goal was to maintain vision while lowering treatment burden and risks from frequent injections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Associated Retinal Consultants
Ann Arbor, Michigan, 49301, United States
-
California Retina Consultants & Research Foundation
Santa Barbara, California, 93103, United States
-
Texas Retina Associates
Arlington, Texas, 76012, United States
Conditions
Explore the condition pages connected to this study.